Skip to main navigation Skip to search Skip to main content

Residual mass and negative gallium scintigraphy in treated lymphoma

  • O. Israel
  • , D. Front
  • , R. Epelbaum
  • , S. Ben-Haim
  • , J. Jerushalmi
  • , U. Kleinhaus
  • , E. Even-Sapir
  • , E. Robinson
  • Rambam Health Care Campus Israel

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Two patients with treated lymphoma demonstrated a residual mass on CT following treatment. In both cases gallium-67 (67Ga) scintigraphy demonstrated increased uptake in the original tumor mass and no uptake in the mass after treatment. In both cases the entire residual tumor mass was resected and found to contain no cancer tissue. This is further evidence of the role 67Ga scintigraphy may play in monitoring response of lymphoma patients to treatment. In contrast, other imaging modalities such as ultrasound, plain film x-rays, or CT only show the presence of a mass but not its nature.

Original languageEnglish
Pages (from-to)365-368
Number of pages4
JournalJournal of Nuclear Medicine
Volume31
Issue number3
StatePublished - Mar 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Residual mass and negative gallium scintigraphy in treated lymphoma'. Together they form a unique fingerprint.

Cite this